|Product Overview:||Recombinant Human PLVAP(Arg123~Lys393) fused with His tag at N-terminal was expressed in E. coli.|
|Form:||PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.|
|Endotoxin:||<1.0EU per 1µg (determined by the LAL method)|
|Applications:||Positive Control; Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein.
|Stability:||The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37 centigrade for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.|
|Storage:||Avoid repeated freeze/thaw cycles. Store at 2-8 centigrade for one month. Aliquot and store at -80 centigrade for 12 months.|
|Reconstitution:||20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.|
|Gene Name:||PLVAP plasmalemma vesicle associated protein [ Homo sapiens ]|
|Synonyms:||PLVAP; plasmalemma vesicle associated protein; plasmalemma vesicle-associated protein; FELS; fenestrated endothelial linked structure protein; PV 1 protein; gp68; PV 1; PV1; plasmalemma vesicle protein 1; fenestrated endothelial-linked structure protein; fenestrated-endothelial linked structure protein; PV-1 protein; PV-1;|
Price does not include shipping and packaging costs.Request quote for final price.